April is National Cancer Control Month and its goal is to boost awareness of cancer, its care and to help more people win the battle against cancer. While it is impossible to completely eliminate the risk of cancer, you can take action to reduce your cancer risk through various lifestyle changes. One key area in your control is making healthy changes to your diet. Instead of just listing these healthy habits, follow the tips below to make your next grocery shopping trip a cancer-fighting experience.
Stick to the list: The very best thing you can do for yourself is to be prepared. Continue reading →
Where would we be without medical advances? Think about medical care 100 years ago. Since then, there’s been an explosion in vaccine development, antibiotics, surgical techniques, medical devices and discovery of medications to treat and control disease. You can look at any medical specialty and see the advances that have been made. Clinical trials represent our era’s research frontier for medical advances.
April is Cancer Control month and one of the goals of cancer control is improving the care for cancer patients. How is this accomplished? Advancements in cancer treatment happen through clinical research. The milestones that have been made over the last 40 years in cancer care are due to research and a patient’s willingness to participate.
These are just a few of the advancements that have been made over the last four decades:
The 5-year survival rate for all childhood cancer combined is now approximately 81%, compared to 62% in 1975
5-year survival for adults is now 68% compared to 50% in 1975
mCancerPartner sat down recently with Khaled S. Hafez, M.D., a surgeon and associate professor of urology, to discuss how kidney cancer is detected and the role biopsies play.
mCancerPartner: What are the symptoms of kidney cancer?
Dr. Hafez: The three symptoms that normally indicate kidney cancer are pain in the abdomen, blood in the urine and a mass, or growth, in the side. But how physicians find kidney cancer has changed in recent years. Today, most kidney cancer is found accidently, before the symptoms Continue reading →
Human KRAS protein. Mutant RAS proteins may play a role in one third of all human cancers.
Mutation of the KRAS gene drives up to 30% of all human cancers, and is especially prevalent among aggressive and hard-to-treat forms — like pancreatic, colon and lung cancers. For decades, researchers have tried to develop drugs to shut down the mutated gene, but a lack of success by pharmaceutical, biotech and academic laboratories has earned this cancer mutation a reputation for being “undruggable.”
New research conducted at the University of Michigan, however, offers a new strategy for disrupting the mutations’ unchecked spread — by attacking a protein complex that protects and supports it. The approach, detailed in a forthcoming article in Neoplasia[DI1] , comes as efforts to combat the mutation have been in the national spotlight. Recently, the National Cancer Institute announced a $10 million-a-year initiative to target KRAS, for which it is repurposing a new high-tech lab at the Frederick National Laboratory for Cancer Research. Continue reading →
Most of us are aware of the common cancer treatment side effects like nausea or hair loss. Many don’t realize that more than one-third of people treated for cancer develop complications that affect the mouth. Chemotherapy and radiation therapy slow or stop growth of fast growing cells, such as cancer cells. Normal cells in the lining of the mouth also grow quickly, so these cancer treatments can stop them from growing too. In turn, this slows down the ability of oral tissue to repair itself by making new cells.